Evidence map›Paper›PMID 33033827›Full record

ArticleChemical senses2020

Gaining Back What Is Lost: Recovering the Sense of Smell in Mild to Moderate Patients After COVID-19.

Lucia Iannuzzi, Anna Eugenia Salzo, Gioacchino Angarano, Vincenzo Ostilio Palmieri, Piero Portincasa, Annalisa Saracino, Matteo Gelardi, Michele Dibattista, Nicola Quaranta

Abstract read
In one paragraph

Article in Chemical senses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Nasal cytological evidence of chronic inflammation in the olfactory cleft in post-viral olfactory dysfunction.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
    Observational
  6. The long-term effect of COVID-19 infection on olfaction and taste; a prospective analysis.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Observational
  7. Effect of drug therapies on self-reported chemosensory outcomes after COVID-19.World journal of otorhinolaryngology - head and neck surgery · 2024
    Article
  8. Article
  9. Recovery Patterns of COVID-19 Related Smell Disorders: An Analysis of the Available Evidence.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Smell Outcome and Seropositivity Titre in Post-COVID-19 Patients.ORL; journal for oto-rhino-laryngology and its related specialties · 2023
    Article
  17. Identifying Olfactory Phenotypes to Differentiate Between COVID-19 Olfactory Dysfunction and Sinonasal Inflammatory Disease.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2022
    Article
  18. What about using sniffin' sticks 12 items test to screen post-COVID-19 olfactory disorders?European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lucia IannuzziENT Clinic, Department of Biomedical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy.
Anna Eugenia SalzoENT Clinic, Department of Biomedical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy.
Gioacchino AngaranoClinic of Infectious Diseases, Department of Biomedical sciences and Human Oncology, University of Bari, Bari, Italy.
Vincenzo Ostilio PalmieriClinica Medica "A. Murri," Department of Biomedical sciences and Human Oncology, University of Bari, Bari, Italy.
Piero PortincasaClinica Medica "A. Murri," Department of Biomedical sciences and Human Oncology, University of Bari, Bari, Italy.
Annalisa SaracinoClinic of Infectious Diseases, Department of Biomedical sciences and Human Oncology, University of Bari, Bari, Italy.
Matteo GelardiENT Clinic, University of Foggia, Foggia, Italy.
Michele DibattistaDepartment of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari A. Moro, Bari, Italy.
Nicola QuarantaENT Clinic, Department of Biomedical Sciences, Neurosciences and Sense Organs, University of Bari, Bari, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of our cohort study was to quantify olfactory deficits in Coronavirus disease 2019 (COVID-19) patients using Sniffin' Sticks and a pre-post design to evaluate olfactory recovery. Thirty adult patients with laboratory-confirmed mild to moderate forms of COVID-19 underwent a quantitative olfactory test performed with the Sniffin' Sticks test (SST; Burghardt, Wedel, Germany), considering olfactory threshold (T), odor discrimination (D), and odor identification (I). Results were presented as a composite TDI score (range 1-48) that used to define functional anosmia (TDI ≤ 16.5), hyposmia (16.5 < TDI < 30.5), or functionally normal ability to smell (TDI ≥ 30.5). Patients also self-evaluated their olfactory function by rating their ability to smell on a visual analogue scale (Visual Analog Scale rating) and answering a validated Italian questionnaire (Hyposmia Rating Scale). Patients were tested during hospitalization and about 2 months after symptoms onset. During the hospitalization, the overall TDI score indicated that our cohort had impairments in their olfactory ability (10% was diagnosed with anosmia and more than 50% were hyposmic). Almost all patients showed a significant improvement at around 1 month following the first test and for all the parts of the SST except for odor identification. None of the subjects at 1 month was still diagnosed with anosmia. We also quantified the improvement in the TDI score based on initial diagnosis. Anosmic subjects showed a greater improvement than hyposmic and normosmic subjects. In conclusion, within a month time window and 2 months after symptoms' onset, in our cohort of patients we observed a substantial improvement in the olfactory abilities.

Indexed as

AdultAnosmiaCOVID-19FemaleHumansMaleMiddle AgedOlfaction DisordersSARS-CoV-2Self ReportSensory ThresholdsSeverity of Illness IndexSmellSurveys and QuestionnairesCOVID-19olfactory deficitsolfactory testSniffin’ Sticks test—SST

Identifiers

PMID33033827
PMCPMC7665358

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.